Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,413 | $3,954 | $4,338 | $8,075 |
| Dep. & Amort. | $483 | $421 | $341 | $286 |
| Deferred Tax | -$757 | -$838 | -$746 | -$147 |
| Stock-Based Comp. | $983 | $885 | $725 | $602 |
| Change in WC | -$618 | -$94 | -$243 | -$1,917 |
| Other Non-Cash | -$82 | $266 | $600 | $182 |
| Operating Cash Flow | $4,421 | $4,594 | $5,015 | $7,081 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$756 | -$926 | -$590 | -$552 |
| Net Acquisitions | -$17 | -$55 | -$230 | $552 |
| Inv. Purchases | -$16,617 | -$11,646 | -$7,488 | -$7,048 |
| Inv. Sales/Matur. | $15,027 | $9,442 | $5,551 | $2,215 |
| Other Inv. Act. | -$106 | $0 | -$1,027 | -$552 |
| Investing Cash Flow | -$2,468 | -$3,185 | -$3,785 | -$5,385 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,465 | $1,146 | $1,520 | $1,672 |
| Stock Repurch. | -$3,632 | -$2,936 | -$2,529 | -$2,678 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$33 | $0 | $0 | $0 |
| Financing Cash Flow | -$2,201 | -$1,790 | -$1,009 | -$1,006 |
| Forex Effect | -$1 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$249 | -$382 | $221 | $691 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,738 | $3,119 | $2,898 | $2,207 |
| End Cash | $2,489 | $2,738 | $3,119 | $2,898 |
| Free Cash Flow | $3,665 | $3,668 | $4,425 | $6,529 |